Yiping Dai

Yiping Dai

Auto-generated profile, based on publicly available information

Yiping Dai

Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2023 in Journal of International Medical Research
Verified
Journal Article
Open access
YDYiping Dai
Yiping Dai
WLWeihua Liu
Weihua Liu
FHFuyuan Hong
Fuyuan Hong
Posterior reversible encephalopathy syndrome (PRES) is a rare clinical disease, which has been seen in patients with systemic lupus erythematosus (SLE). Its main manifestations are seizure, headache and other neurological symptoms. While the condition is reversible, if not treated in time, there can be risks of cerebral haemorrhage. We report here the case of a young patient with SLE who developed PRES after receiving the immunosuppressant, mycophenolate mofetil. Neurological symptoms, signs, or changes in a patient’s condition that cannot be explained by lupus, should alert physicians to the possibility of the drug causing PRES, and prompt discontinuation should ensue.